HYZAAR (50+ 12,5) MG COM REV CT BL AL PLAS OPC X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1002900130026 -
GGREM
525501202118317 -
Código de barras
7897337709354
O que a fonte publica
- Detentor do registro
- ORGANON FARMACEUTICA LTDA.
- Princípios ativos
- LOSARTANA POTÁSSICA;HIDROCLOROTIAZIDA
- Embalagem
- (50+ 12,5) MG COM REV CT BL AL PLAS OPC X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- C9D1 - ANTAGONISTAS DA ANGIOTENSINA II ASSOCIADOS A ANTIHIPERTENSIVOS (C2) E/OU DIURÉTICOS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "HYZAAR (50+ 12,5) MG COM REV CT BL AL PLAS OPC X 30",
"holder": "ORGANON FARMACEUTICA LTDA.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7897337709354"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "525501202118317",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "45.987.013/0001-34",
"priceRegime": "Regulado",
"productName": "HYZAAR",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "(50+ 12,5) MG COM REV CT BL AL PLAS OPC X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "50.11",
"icms-12": "56.94",
"icms-17": "60.37",
"icms-18": "61.11",
"icms-19": "61.86",
"icms-20": "62.64",
"icms-21": "63.43",
"icms-22": "64.24",
"icms-23": "65.08",
"icms-17.5": "60.74",
"icms-19.5": "62.25",
"icms-20.5": "63.03",
"icms-22.5": "64.66",
"icms-12-alc": "56.26",
"icms-17-alc": "59.65",
"icms-18-alc": "60.38",
"icms-19-alc": "61.12",
"icms-20-alc": "61.89",
"icms-21-alc": "62.67",
"icms-22-alc": "63.47",
"icms-23-alc": "64.30",
"withoutTaxes": "49.51",
"icms-17.5-alc": "60.01",
"icms-19.5-alc": "61.50",
"icms-20.5-alc": "62.28",
"icms-22.5-alc": "63.88"
},
"pisCofinsList": "Positiva",
"substanceText": "LOSARTANA POTÁSSICA;HIDROCLOROTIAZIDA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "69.07",
"icms-12": "78.49",
"icms-17": "83.21",
"icms-18": "84.23",
"icms-19": "85.27",
"icms-20": "86.34",
"icms-21": "87.43",
"icms-22": "88.55",
"icms-23": "89.71",
"icms-17.5": "83.72",
"icms-19.5": "85.81",
"icms-20.5": "86.88",
"icms-22.5": "89.13",
"icms-12-alc": "77.78",
"icms-17-alc": "82.46",
"icms-18-alc": "83.47",
"icms-19-alc": "84.49",
"icms-20-alc": "85.56",
"icms-21-alc": "86.64",
"icms-22-alc": "87.74",
"icms-23-alc": "88.89",
"withoutTaxes": "68.44",
"icms-17.5-alc": "82.96",
"icms-19.5-alc": "85.02",
"icms-20.5-alc": "86.10",
"icms-22.5-alc": "88.31"
},
"invalidBarcodes": [],
"activeSubstances": [
"LOSARTANA POTÁSSICA",
"HIDROCLOROTIAZIDA"
],
"therapeuticClass": "C9D1 - ANTAGONISTAS DA ANGIOTENSINA II ASSOCIADOS A ANTIHIPERTENSIVOS (C2) E/OU DIURÉTICOS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1002900130026",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "C9D1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:525501202118317"